Drugmakers are racing to develop vaccines and drugs to address the worst outbreak of Ebola in history Its unclear who will pay for their products but companies are betting that governments and aid groups will foot the bill Governments and corporations now are shifting millions of dollars to fight Ebola Experts say drugmakers are wagering that international groups and wealthier governments like the US will buy Ebola vaccines and drugs in mass quantities to stockpile them for future use once theyre deemed safe While there are no reliable estimates of the potential market size for an Ebola drug or vaccine some drugmakers have already seen their stocks rise on the potential of the therapies in their pipelines  The Associated Press